Evaluation of a new commercial assay to measure microparticle tissue factor activity in plasma: Communication from the SSC of the ISTH

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 11, 2014, Pages 1932-1934

  Tatsumi, K ^a   Antoniak, S ^a   Monroe, D M ^a   Khorana, A A ^b   Mackman, N ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC KIT; THROMBOPLASTIN;

BLOOD CLOTTING; BLOOD CLOTTING TEST; DIAGNOSTIC KIT; EVALUATION STUDY; HUMAN; MEMBRANE MICROPARTICLE; METABOLISM; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; CELL-DERIVED MICROPARTICLES; HUMANS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; THROMBOPLASTIN;

EID: 84920283531     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12718     Document Type: Article

References (9)

1. Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108: 1284-97.
2. Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, Mackman N, Taubman MB. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Hemost 2008; 6: 1983-5.
3. Lee RD, Barcel DA, Williams JC, Wang JG, Boles JC, Manly DA, Key NS, Mackman N. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res 2012; 129: 80-5.
4. Key NS, Mackman N. Tissue factor and its measurment in whole blood, plasma and microparticles. Semin Thromb Hemost 2010; 36: 866-75.
5. Tesselaar ME, Romijn FP, van der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Hemost 2007; 5: 520-7.
6. Geddings JE, Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 2013; 122: 1873-80.
7. Thaler J, Ay C, Mackman N, Bertina RM, Kaider A, Marosi C, Key NS, Barcel DA, Scheithauer W, Kornek G, Zielinski C, Pabinger I. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Hemost 2012; 10: 1363-70.
8. Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, Mantha S, Kessler CM, Eneman J, Raghavan V, Lenz HJ, Bullock A, Buckbinder E, Neubeg D, Furie B. Prediction and prevention of thrombotic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol 2013; 160: 530-7.
9. Bom VJ, Bertina RM. The contributions of Ca2+, phospholipid and tissue factor apoprotein to the activation of human blood factor X by activated factor VII. Biochem J 1990; 265: 327-36.